[English] 日本語
Yorodumi
- PDB-1aqd: HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEI... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 1aqd
TitleHLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
Components
  • (HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN) x 2
  • HLA-A2
KeywordsCOMPLEX (MHC PROTEIN/ANTIGEN) / COMPLEX (MHC PROTEIN-ANTIGEN) / HISTOCOMPATIBILITY ANTIGEN / COMPLEX (MHC PROTEIN-ANTIGEN) complex
Function / homology
Function and homology information


regulation of interleukin-4 production / regulation of interleukin-10 production / myeloid dendritic cell antigen processing and presentation / antigen processing and presentation of endogenous peptide antigen via MHC class II / autolysosome membrane / regulation of T-helper cell differentiation / positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation / MHC class II receptor activity / positive regulation of CD4-positive, alpha-beta T cell activation / antigen processing and presentation of peptide or polysaccharide antigen via MHC class II ...regulation of interleukin-4 production / regulation of interleukin-10 production / myeloid dendritic cell antigen processing and presentation / antigen processing and presentation of endogenous peptide antigen via MHC class II / autolysosome membrane / regulation of T-helper cell differentiation / positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation / MHC class II receptor activity / positive regulation of CD4-positive, alpha-beta T cell activation / antigen processing and presentation of peptide or polysaccharide antigen via MHC class II / positive regulation of T cell mediated immune response to tumor cell / positive regulation of kinase activity / positive regulation of memory T cell differentiation / positive regulation of monocyte differentiation / inflammatory response to antigenic stimulus / CD4 receptor binding / intermediate filament / positive regulation of memory T cell activation / T cell mediated cytotoxicity directed against tumor cell target / TAP complex binding / Golgi medial cisterna / T-helper 1 type immune response / positive regulation of CD8-positive, alpha-beta T cell activation / CD8-positive, alpha-beta T cell activation / positive regulation of CD8-positive, alpha-beta T cell proliferation / transport vesicle membrane / CD8 receptor binding / Translocation of ZAP-70 to Immunological synapse / antigen processing and presentation of exogenous peptide antigen via MHC class I / Phosphorylation of CD3 and TCR zeta chains / beta-2-microglobulin binding / endoplasmic reticulum exit site / polysaccharide binding / negative regulation of type II interferon production / TAP binding / antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent / humoral immune response / protection from natural killer cell mediated cytotoxicity / macrophage differentiation / Generation of second messenger molecules / immunological synapse / Co-inhibition by PD-1 / antigen processing and presentation of endogenous peptide antigen via MHC class Ib / antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent / epidermis development / positive regulation of insulin secretion involved in cellular response to glucose stimulus / detection of bacterium / T cell receptor binding / negative regulation of T cell proliferation / MHC class II antigen presentation / Nef mediated downregulation of MHC class I complex cell surface expression / trans-Golgi network membrane / Endosomal/Vacuolar pathway / Antigen Presentation: Folding, assembly and peptide loading of class I MHC / protein tetramerization / peptide antigen assembly with MHC class II protein complex / lumenal side of endoplasmic reticulum membrane / negative regulation of inflammatory response to antigenic stimulus / MHC class II protein complex / clathrin-coated endocytic vesicle membrane / ER to Golgi transport vesicle membrane / peptide antigen assembly with MHC class I protein complex / MHC class I peptide loading complex / T cell mediated cytotoxicity / positive regulation of T cell cytokine production / antigen processing and presentation of endogenous peptide antigen via MHC class I / antigen processing and presentation of exogenous peptide antigen via MHC class II / positive regulation of immune response / MHC class I protein complex / positive regulation of T cell activation / peptide antigen binding / structural constituent of cytoskeleton / positive regulation of T cell mediated cytotoxicity / cognition / positive regulation of type II interferon production / phagocytic vesicle membrane / recycling endosome membrane / positive regulation of protein phosphorylation / Interferon gamma signaling / Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell / MHC class II protein complex binding / Interferon alpha/beta signaling / endocytic vesicle membrane / late endosome membrane / antibacterial humoral response / Downstream TCR signaling / T cell receptor signaling pathway / E3 ubiquitin ligases ubiquitinate target proteins / ER-Phagosome pathway / early endosome membrane / adaptive immune response / positive regulation of viral entry into host cell / lysosome / positive regulation of ERK1 and ERK2 cascade / positive regulation of canonical NF-kappaB signal transduction / positive regulation of MAPK cascade / defense response to Gram-positive bacterium / immune response / signaling receptor binding / Golgi membrane
Similarity search - Function
Class II Histocompatibility Antigen, M Beta Chain; Chain B, domain 1 / Class II Histocompatibility Antigen, M Beta Chain; Chain B, domain 1 / MHC class II, beta chain, N-terminal / Class II histocompatibility antigen, beta domain / Class II histocompatibility antigen, beta domain / MHC class II, alpha chain, N-terminal / Class II histocompatibility antigen, alpha domain / Class II histocompatibility antigen, alpha domain / MHC class II, alpha/beta chain, N-terminal / MHC class I, alpha chain, C-terminal ...Class II Histocompatibility Antigen, M Beta Chain; Chain B, domain 1 / Class II Histocompatibility Antigen, M Beta Chain; Chain B, domain 1 / MHC class II, beta chain, N-terminal / Class II histocompatibility antigen, beta domain / Class II histocompatibility antigen, beta domain / MHC class II, alpha chain, N-terminal / Class II histocompatibility antigen, alpha domain / Class II histocompatibility antigen, alpha domain / MHC class II, alpha/beta chain, N-terminal / MHC class I, alpha chain, C-terminal / MHC_I C-terminus / MHC class I alpha chain, alpha1 alpha2 domains / Class I Histocompatibility antigen, domains alpha 1 and 2 / : / MHC class I-like antigen recognition-like / MHC class I-like antigen recognition-like superfamily / MHC classes I/II-like antigen recognition protein / : / Immunoglobulin/major histocompatibility complex, conserved site / Immunoglobulins and major histocompatibility complex proteins signature. / Immunoglobulin C-Type / Immunoglobulin C1-set / Immunoglobulin C1-set domain / Ig-like domain profile. / Immunoglobulin-like domain / Immunoglobulin-like domain superfamily / Roll / Immunoglobulin-like fold / Immunoglobulins / Immunoglobulin-like / Sandwich / Mainly Beta / Alpha Beta
Similarity search - Domain/homology
HLA class I histocompatibility antigen, A alpha chain / HLA class II histocompatibility antigen, DR alpha chain / HLA class II histocompatibility antigen, DRB1 beta chain / HLA class II histocompatibility antigen, DRB1 beta chain / HLA class I histocompatibility antigen, A alpha chain
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.45 Å
AuthorsMurthy, V.L. / Stern, L.J.
Citation
Journal: Structure / Year: 1997
Title: The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
Authors: Murthy, V.L. / Stern, L.J.
#1: Journal: Thesis / Year: 1996
Title: Three Dimensional Structure of a Human Class II Mhc Protein Hla-Dr1 Bound to an Endogenous Peptide
Authors: Murthy, V.L.
#2: Journal: Nature / Year: 1994
Title: Crystal Structure of the Human Class II Mhc Protein Hla-Dr1 Complexed with an Influenza Virus Peptide
Authors: Stern, L.J. / Brown, J.H. / Jardetzky, T.S. / Gorga, J.C. / Urban, R.G. / Strominger, J.L. / Wiley, D.C.
#3: Journal: Nature / Year: 1993
Title: Three-Dimensional Structure of the Human Class II Histocompatibility Antigen Hla-Dr1
Authors: Brown, J.H. / Jardetzky, T.S. / Gorga, J.C. / Stern, L.J. / Urban, R.G. / Strominger, J.L. / Wiley, D.C.
History
DepositionJul 28, 1997Processing site: BNL
Revision 1.0Jan 28, 1998Provider: repository / Type: Initial release
Revision 1.1Mar 24, 2008Group: Version format compliance
Revision 1.2Jul 13, 2011Group: Version format compliance
Revision 1.3Aug 2, 2023Group: Database references / Refinement description / Category: database_2 / pdbx_initial_refinement_model
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession
Revision 1.4Nov 20, 2024Group: Data collection / Structure summary
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / pdbx_entry_details / pdbx_modification_feature

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
B: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
C: HLA-A2
D: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
E: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
F: HLA-A2
G: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
H: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
I: HLA-A2
J: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
K: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
L: HLA-A2


Theoretical massNumber of molelcules
Total (without water)188,14712
Polymers188,14712
Non-polymers00
Water2,738152
1
A: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
B: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
C: HLA-A2


Theoretical massNumber of molelcules
Total (without water)47,0373
Polymers47,0373
Non-polymers00
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area7400 Å2
ΔGint-35 kcal/mol
Surface area17620 Å2
MethodPISA
2
G: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
H: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
I: HLA-A2


Theoretical massNumber of molelcules
Total (without water)47,0373
Polymers47,0373
Non-polymers00
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area7370 Å2
ΔGint-37 kcal/mol
Surface area17440 Å2
MethodPISA
3
D: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
E: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
F: HLA-A2


Theoretical massNumber of molelcules
Total (without water)47,0373
Polymers47,0373
Non-polymers00
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area7360 Å2
ΔGint-38 kcal/mol
Surface area17340 Å2
MethodPISA
4
J: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
K: HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN
L: HLA-A2


Theoretical massNumber of molelcules
Total (without water)47,0373
Polymers47,0373
Non-polymers00
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area7440 Å2
ΔGint-37 kcal/mol
Surface area17470 Å2
MethodPISA
Unit cell
Length a, b, c (Å)134.514, 134.320, 131.232
Angle α, β, γ (deg.)90.00, 104.82, 90.00
Int Tables number5
Space group name H-MC121
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-ID
11
22
33
/ NCS ensembles :
ID
1
2
3

NCS oper:
IDCodeMatrixVector
1given(-0.79191, 0.53255, 0.29877), (0.51517, 0.32, 0.79511), (0.32783, 0.78358, -0.52777)27.22638, -39.64445, 49.03718
2given(0.00458, -0.99941, -0.03407), (0.9993, 0.00584, -0.03683), (0.037, -0.03388, 0.99874)45.1323, -22.11342, -61.74336
3given(-0.51898, -0.34098, -0.78383), (-0.79916, 0.51896, 0.30336), (0.30334, 0.78384, -0.54183)83.35107, 3.8172, -10.51804
DetailsTHERE ARE FOUR MOLECULES IN THIS COORDINATE SET EACH MOLECULE HAS ONE ALPHA CHAIN : RESIDUES 3-182 EACH MOLECULE HAS ONE BETA CHAIN : RESIDUES 4-190 EACH MOLECULE HAS ONE PEPTIDE CHAIN: RESIDUES 3-14 MOLECULE THREE IS THE MOST WELL DEFINED. MOLECULES 1 - 2 AND 3 - 4 EACH FORM THE SO-CALLED "DIMER OF DIMERS".

-
Components

#1: Protein
HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN / DRA / DRB1 01010


Mass: 22222.027 Da / Num. of mol.: 4 / Fragment: SECRETED EXTRACELLULAR DOMAINS
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Tissue: LYMPHOID / Cellular location: PLASMA MEMBRANE / Gene: DRA*0101, DRB1*0101 / Organ: PLASMA / Cell line (production host): SF9 / Production host: Spodoptera frugiperda (fall armyworm) / References: UniProt: P01903
#2: Protein
HLA-DR1 CLASS II HISTOCOMPATIBILITY PROTEIN / DRA / DRB1 01010


Mass: 22956.596 Da / Num. of mol.: 4 / Fragment: SECRETED EXTRACELLULAR DOMAINS
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Tissue: LYMPHOID / Cellular location: PLASMA MEMBRANE / Gene: DRA*0101, DRB1*0101 / Organ: PLASMA / Cell line (production host): SF9 / Production host: Spodoptera frugiperda (fall armyworm) / References: UniProt: P04229, UniProt: P01911*PLUS
#3: Protein/peptide
HLA-A2


Mass: 1858.045 Da / Num. of mol.: 4 / Fragment: ANTIGENIC PEPTIDE
Source method: isolated from a genetically manipulated source
Details: HLA-DR1 IS A CLASS II MHC PROTEIN, HLA-A2 IS A CLASS I HISTOCOMPATIBILITY ANTIGEN
Source: (gene. exp.) Homo sapiens (human) / References: UniProt: P01892, UniProt: P04439*PLUS
#4: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 152 / Source method: isolated from a natural source / Formula: H2O
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 3.04 Å3/Da / Density % sol: 56.2 %
Crystal growpH: 3.5
Details: CRYSTALS GREW AS NEEDLES FROM 10MG/ML HLA-DR1 / PEPTIDE COMPLEX, 15% PEG 4000, 100MM GLYCINE, PH 3.5, AT ROOM TEMPERATURE, OVER ONE WEEK.
Temp details: room temp
Crystal
*PLUS
Crystal grow
*PLUS
Method: unknown
Components of the solutions
*PLUS
IDConc.Common nameCrystal-IDSol-ID
110 mg/mlprotein11
215 %PEG400011
3100 mMglycine11

-
Data collection

DiffractionMean temperature: 98 K
Diffraction sourceSource: SYNCHROTRON / Site: CHESS / Beamline: F1 / Wavelength: 0.918
DetectorType: FUJI / Detector: IMAGE PLATE / Date: Feb 1, 1995
RadiationMonochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.918 Å / Relative weight: 1
ReflectionResolution: 2.45→20 Å / Num. obs: 73538 / % possible obs: 85 % / Observed criterion σ(I): 2 / Redundancy: 2.1 % / Biso Wilson estimate: 37.2 Å2 / Rsym value: 0.07 / Net I/σ(I): 14.9
Reflection shellResolution: 2.45→2.57 Å / Redundancy: 1.8 % / Mean I/σ(I) obs: 4.4 / Rsym value: 0.331 / % possible all: 70
Reflection
*PLUS
Num. measured all: 157895 / Rmerge(I) obs: 0.07
Reflection shell
*PLUS
% possible obs: 70 % / Num. unique obs: 7700 / Num. measured obs: 13661 / Rmerge(I) obs: 0.331

-
Processing

Software
NameVersionClassification
DENZOdata reduction
SCALEPACKdata scaling
X-PLOR3.1model building
X-PLOR3.1refinement
X-PLOR3.1phasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: PDB ENTRY 1DLH

1dlh


Resolution: 2.45→6 Å / Isotropic thermal model: RESTRAINED / Cross valid method: THROUGHOUT / σ(F): 2 / Details: REFMAC USED IN LATER STAGES OF REFINEMENT.
RfactorNum. reflection% reflectionSelection details
Rfree0.279 6884 10 %RANDOM
Rwork0.216 ---
obs0.216 68842 89 %-
Displacement parametersBiso mean: 40.8 Å2
Refine analyze
FreeObs
Luzzati coordinate error0.4 Å0.3 Å
Luzzati d res low-5 Å
Luzzati sigma a-0.27 Å
Refinement stepCycle: LAST / Resolution: 2.45→6 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms11867 0 0 152 12019
Refine LS restraints
Refine-IDTypeDev ideal
X-RAY DIFFRACTIONx_bond_d0.016
X-RAY DIFFRACTIONx_bond_d_na
X-RAY DIFFRACTIONx_bond_d_prot
X-RAY DIFFRACTIONx_angle_d
X-RAY DIFFRACTIONx_angle_d_na
X-RAY DIFFRACTIONx_angle_d_prot
X-RAY DIFFRACTIONx_angle_deg2.6
X-RAY DIFFRACTIONx_angle_deg_na
X-RAY DIFFRACTIONx_angle_deg_prot
X-RAY DIFFRACTIONx_dihedral_angle_d26
X-RAY DIFFRACTIONx_dihedral_angle_d_na
X-RAY DIFFRACTIONx_dihedral_angle_d_prot
X-RAY DIFFRACTIONx_improper_angle_d
X-RAY DIFFRACTIONx_improper_angle_d_na
X-RAY DIFFRACTIONx_improper_angle_d_prot
X-RAY DIFFRACTIONx_mcbond_it0.15
X-RAY DIFFRACTIONx_mcangle_it0.2
X-RAY DIFFRACTIONx_scbond_it0.2
X-RAY DIFFRACTIONx_scangle_it0.25
Refine LS restraints NCS
Ens-IDDom-IDNCS model detailsRefine-IDRms dev Biso (Å2)Rms dev position (Å)
11RESTRAINTS (INTER AND INTRADIMER)X-RAY DIFFRACTION0.10.1
22X-RAY DIFFRACTION0.10.1
33X-RAY DIFFRACTION0.10.1
LS refinement shellResolution: 2.45→2.57 Å / Total num. of bins used: 8
RfactorNum. reflection% reflection
Rfree0.354 770 10 %
Rwork0.319 6930 -
obs--70 %
Xplor file
Refine-IDSerial noParam fileTopol file
X-RAY DIFFRACTION1PARAMHCSDX.PROTOPHCSDX.PRO
X-RAY DIFFRACTION2PARAM19.SOLTOPH19.SOL
X-RAY DIFFRACTION3PARAM3_MOD.CHOTOPH3.CHO
Software
*PLUS
Name: X-PLOR / Version: 3.1 / Classification: refinement
Refine LS restraints
*PLUS
Refine-IDTypeDev ideal
X-RAY DIFFRACTIONx_dihedral_angle_d
X-RAY DIFFRACTIONx_dihedral_angle_deg26

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more